You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
爱康医疗(01789.HK)拟斥资4020万美元收购北京理贝尔生物工程研究所全部股权
格隆汇 04-06 20:49

格隆汇4月6日丨爱康医疗(01789.HK)发布公告,2020年4月6日,公司间接全资附属公司爱康医疗国际有限公司作为买方与美敦力康辉控股(中国)公司订立购股协议,据此,卖方同意出售北京理贝尔生物工程研究所有限公司全部股权,总代价为4020万美元(可予调整),并须以现金结算。

目标公司北京理贝尔生物工程研究所有限公司为一间根据中国法律成立的有限公司,由卖方全资拥有,为于中国从事生产、销售及研究骨科植入物及手术器械的公司。

公告表示,目标公司是一家具有历史和品牌知名度的中国骨科企业,在设计开发及制造骨科植入物及手术工具方面拥有专业的知识和技术。董事会认为,成为中国骨科领域的领导者之一是集团的长期战略目标,收购目标公司与集团的这一战略目标一致,并将于未来提高集团的整体财务表现。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account